IBRX: ImmunityBio, Inc. Stock

by  •  • Comments Off on IBRX: ImmunityBio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,497.16
Enterprise Value ($M) 3,361.12
Book Value ($M) -744.16
Book Value / Share -1.02
Price / Book -3.36
NCAV ($M) -945.58
NCAV / Share -1.30
Price / NCAV -2.64

Profitability (mra)
Return on Invested Capital (ROIC) -2.14
Return on Assets (ROA) -1.17
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.64
Current Ratio 2.68

Balance Sheet (mrq) ($M)
Current Assets 163.15
Assets 364.57
Liabilities 1,108.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 911,051 3,944,817 23.09
2025-02-21 1,033,732 4,685,309 22.06
2025-02-20 1,685,909 5,860,285 28.77
2025-02-19 4,508,154 17,941,804 25.13

(click for more detail)

Similar Companies
HLVX – HilleVax, Inc. HOWL – Werewolf Therapeutics, Inc.
HUMA – Humacyte, Inc. IDXX – IDEXX Laboratories, Inc.
IDYA – IDEAYA Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io